+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "AIDS"

Global HIV Self Testing Market Outlook 2027 - Product Thumbnail Image

Global HIV Self Testing Market Outlook 2027

  • Report
  • February 2020
  • 211 Pages
  • Global
From
From
From
From
Disease Analysis: HIV Pre-Exposure Prophylaxis (HIV PrEP) - Product Thumbnail Image

Disease Analysis: HIV Pre-Exposure Prophylaxis (HIV PrEP)

  • Report
  • April 2021
  • 47 Pages
  • Global
Disease Analysis: HIV Treatment - Product Thumbnail Image

Disease Analysis: HIV Treatment

  • Report
  • April 2021
  • 64 Pages
  • Global
HIV Disease Coverage Forecast and Market Analysis to 2024 - Product Thumbnail Image

HIV Disease Coverage Forecast and Market Analysis to 2024

  • Report
  • January 2019
  • 717 Pages
  • Global
From
Loading Indicator

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments. The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more